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Abbreviations
Ago  Argonaute
ARe  AU-rich element
CLIP  Uv crosslinking and immunoprecipitation
CLASH  Crosslinking, ligation and sequencing of 
hybrids




HuR  Human antigen R
miRISC  miRNA induced silencing complex
miPDC  miRNA precursor deposit complex
miRNA  MicroRNA
MRe  microRNA response element
NeS  Nuclear export signal
NLS  Nuclear localization signal
ncRNA  Non-coding RNA
P-body  Processing body
PABP  PolyA-binding protein
PACT  Protein activator of PKR kinase
pri-miRNA  miRNA primary transcript
pre-miRNA  miRNA precursor
RBP  RNA-binding protein
RLC  RISC-loading complex
RNP  Ribonucleic acid protein complex
RRM  RNA recognition motif
siRNA  Small interfering RNA
TRBP  HIv-1 transactivation response RNA-bind-
ing protein
Introduction
MicroRNAs (miRNAs) constitute a large family of short, 
non-coding RNAs (ncRNAs) (~22 nucleotides long) that 
Abstract MicroRNAs comprise a large family of short, 
non-coding RNAs that are present in most eukaryotic 
organisms and are typically involved in downregulating the 
expression of protein-coding genes. The detailed mecha-
nisms of miRNA functioning in animals and plants have 
been under investigation for more than decade. In mam-
malian cells, miRNA guides the effector complex miRISC 
to bind with partially complementary sequences, usually 
within the 3′UTR of mRNAs, and inhibit protein synthe-
sis with or without transcript degradation. In addition to 
these main mechanisms, several other modes of miRNA-
mediated gene expression regulation have been described, 
but their scale and importance remain a matter of debate. In 
this review, we briefly summarize the pathway of miRNA 
precursor processing during miRNA biogenesis and con-
tinue with the description of the miRISC assembly process. 
Then, we present the miRNA-mediated mechanisms of 
gene expression regulation in detail, and we gather infor-
mation concerning the proteins involved in these processes. 
In addition, we briefly refer to the current applications of 
miRNA mechanisms in therapeutic strategies. Finally, we 
highlight some of the remaining controversies surrounding 
the regulation of mammalian gene expression by miRNAs.
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are common in single-celled eukaryotes, plant and animal 
cells [1], and have also been found in virus genomes [2, 3]. 
In humans, more than 2,500 miRNAs have already been 
discovered (collected in the miRBase 20.0 database) [4].
MicroRNAs play a crucial role in the post-transcrip-
tional regulation of gene expression, mostly involving gene 
silencing. These tiny RNAs are generated in cells through 
a biogenesis pathway that involves the two-step enzymatic 
processing of genome-encoded primary miRNA transcripts 
into short miRNA/miRNA* duplexes. During assembly 
of the miRNA-induced silencing complex (miRISC), the 
miRNA/miRNA* duplex is loaded into the Argonaute 
protein (Ago), and one of the strands (called the “passen-
ger strand”) is released and degraded. Consequently, the 
bound miRNA strand (the “guide strand”) guides miRISC 
to interact with partially complementary sequences in tar-
get transcripts (mostly localized within the 3′UTR) and 
mainly triggers mRNA deadenylation and degradation or 
translation inhibition. However, several other mechanisms 
of gene expression regulation by miRNAs have also been 
described. The key attribute of miRNA is imperfect base 
pairing within miRNA/miRNA* duplexes as well as within 
duplexes formed by the miRNA and its target mRNA. It 
is estimated that most protein-coding genes are regulated 
by miRNAs [5, 6]. Thus, it is not surprising that miRNA 
deregulation influences cell physiology and triggers numer-
ous pathological states.
In this review, after gathering the relevant information 
on miRNA biogenesis and miRISC assembly, we focus on 
the recent understanding of cellular mechanisms of gene 
expression regulation by miRNAs. This topic still arouses 
researchers’ curiosity because of the controversies around a 
detailed scheme of miRNA-mediated mechanisms.
Overview of miRNA biogenesis
The canonical biogenesis pathway of mammalian miRNAs 
(Fig. 1a) is a two-step (nuclear and cytoplasmic) enzymatic 
processing of their precursors, which are encoded in the 
genome (reviewed in [7, 8]). miRNA genes are localized 
either between protein-coding genes or in their intron ele-
ments. Briefly, miRNA genes are typically transcribed by 
RNA polymerase II [9, 10], or less frequently by RNA 
polymerase III (Fig. 1.1) [11], to produce long primary 
miRNA transcripts (pri-miRNA) containing a stem-loop 
structure. Pri-miRNAs are co-transcriptionally recognized 
by a large protein complex, called the Microprocessor, the 
main components of which are the RNase III Drosha and 
DGCR8 [12–16]. Drosha is responsible for pri-miRNA 
cleavage—in a process called “cropping”—into ~60 nucle-
otides long, hairpin-structured pre-miRNA (Fig. 1.2) [12, 
17]. Next, pre-miRNAs are actively transported from the 
nucleus into the cytoplasm by exportin-5 (exp-5) (Fig. 1.3) 
[18, 19]. In the cytoplasm, another RNase III, Dicer, func-
tioning with its protein partners Ago2, TRBP and/or PACT 
[20–24], recognizes the pre-miRNAs and cleaves them into 
miRNA/miRNA* duplexes of approximately 22-nucleotide 
Fig. 1  miRNA biogenesis in 
human cells. a The canonical 
pathway covers 1 pri-miRNA 
transcription, 2 Drosha cleav-
age, 3 pre-miRNA export to 
cytoplasm and 4 Dicer cleavage 
into 5 the miRNA/miRNA* 
duplex. b The alternative 
Drosha-independent biogenesis 
pathway (mirtron pathway) is 
indicated by the orange dashed 
line. See text for more details
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length in a process termed “dicing” [25–28] (Fig. 1.4, 5). 
In addition to the canonical pathway of miRNA biogene-
sis described above (Fig. 1a), other pathways exist that are 
independent of Drosha (wherein miRNAs are generated 
from pre-miRNA-like introns, called mirtrons) (Fig. 1b) 
[29, 30] or Dicer activity [31–33].
RNase III enzymes (Drosha and Dicer) cleave miRNA 
precursors imprecisely and generate heterogeneous prod-
ucts that often differ in length [28, 34–36]. These length 
variants and shifted miRNA sequences are called isomiR-
NAs (isomiRs) [34]. The isomiRs may vary in their regu-
lation of gene expression because of changes in their tar-
get specificity (reviewed in [37]). Some isomiRs, however, 
may regulate the same targets as the canonical miRNAs 
[38, 39].
Apart from isomiRs, the pool of miRNAs may be varied 
by the competitive processes of post-transcriptional, non-
templated oligo-adenylation [35, 40–42] or oligo-uridyla-
tion [43] at the 3′ termini of pre-miRNAs ([44], reviewed 
in [45, 46]). In general, the addition of the U-residues to 
the 3′ end of RNAs serves as a molecular signal for deg-
radation ([43, 47–49], reviewed in [50]), whereas the extra 
A-residues tend to increase miRNA stability [41]. Moreo-
ver, miRNA precursors might be substrates for adenosine 
deaminase acting on RNA (ADAR), which converts A-res-
idues into inosine, causing A-to-I RNA editing [51–53]. 
Inosine pairs with C- instead of U-residues; hence, it may 
alter the structure and properties of modified RNA. As a 
consequence of miRNA precursor sequence modifications 
by ADAR, several effects may occur, such as miRNA pro-
cessing inhibition [52, 54, 55], miRISC loading repression 
[56] or changes in the repertoire of the targeted genes (redi-
rection of targets) ([57], reviewed in [58]).
miRISC assembly
miRNA/miRNA* duplexes are incorporated into a ribonu-
cleoprotein (RNP) complex—called miRISC—that plays 
a crucial role in the miRNA-mediated mechanism of gene 
expression regulation. The core component of miRISC 
is a protein from the Argonaute subfamily, which is char-
acterized in human cells by the existence of four paralogs: 
Ago1-4 (reviewed in [59, 60]). Ago proteins consist of four 
domains: PAZ (binds the 3′ end of the miRNA strand), 
Mid (binds the 5′-phosphate group of the miRNA), C-ter-
minal PIwI (may possess endonucleolytic activity) and the 
N-terminal domain (facilitates duplex unwinding) (Fig. 2a). 
earlier findings regarding the roles of Ago domains [61–
65] have been recently confirmed by the determination of 
the three-dimensional structure of human Ago2 alone [66] 
and in a complex with miR-20a [67]. Among the Ago par-
alogs, only Ago2 (also called “Slicer”) is characterized by 
siRNA-induced endonuclease activity toward complemen-
tary mRNA sequences [61, 68–70] because of the specific 
structural [69, 71] and functional [72, 73] features of its 
PIwI domain, which is similar to that observed in RNase 
H [74]. As it was discovered that miRNAs and siRNAs in 
Drosophila melanogaster cells are sorted into different Ago 
paralogs ([75–78], reviewed in [79]), it was thought that 
such sorting may also occur in mammalian cells. However, 
no miRNA preference for a particular Ago protein paralog 
has been found by the deep sequencing of miRNAs bound to 
immunoprecipitated Ago proteins [80]. In addition, accord-
ing to shotgun proteomic analysis, miRNAs are sorted ran-
domly depending on the abundance of Ago paralogs [81].
Mature miRISC is formed in a multistep assembly pro-
cess (Fig. 2) (reviewed in [82]). The first step is miRISC 
loading and the formation of pre-miRISC, when the 
miRNA duplex is transferred from Dicer to Ago within the 
RISC loading complex (RLC); this process requires ATP 
[83–85] and the 5′ phosphate of miRNAs [83]. Interest-
ingly, it has also been shown that miRISC loading might be 
preceded by miRNA precursor deposit complex (miPDC) 
formation [86]. The major components of RLC are Dicer, 
Ago, TRBP and/or PACT (Fig. 2a) [20, 21, 87, 88], and 
these proteins were shown to participate in strand selection 
[89–91]. However, the detailed composition of RLC is still 
under investigation, and it has been suggested that Dicer is 
not essential in asymmetric miRISC loading [92–94].
It has been shown that either strand from a duplex can 
be a guide or a passenger strand [95–99]. The selection of 
a guide strand is thought to depend on the relative thermo-
dynamic stability of miRNA ends, referred to as the “asym-
metry rule.” The strand with the less stable 5′ end base 
pairing in the duplex is typically retained by miRISC [100–
102]. Moreover, on the 5′ end of the miRNA guide strands, 
A- and U-residues are much more preferable for the 
miRISC loading step than are G- or C-residues [103]. Other 
factors contributing to the efficiency of duplex loading and 
unwinding are structural features of the miRNA/miRNA* 
duplexes (e.g., the position of base mismatches) and their 
sequence composition [84, 85, 104]. Taken together, the 
differences and changes in the miRNA sequence, such as 
those observed in isomiRs or edited miRNAs, may affect 
guide-strand selection [105].
miRISC loading is thought to be continued with an active 
wedging of the Ago N-terminal domain between duplex 
strands (Fig. 2b) [106] and duplex unwinding by the Ago 
PAZ domain (Fig. 2c) [107]. As a result, one strand from 
a duplex is removed from pre-miRISC and undergoes rapid 
exonuclease-mediated degradation (Fig. 2d) (reviewed in 
[46]). Hence, the interaction of Ago proteins with miRNAs 
[67, 108–110] increases miRNA stability in the cell. Simi-
larly, Ago cellular stability is enhanced by miRNA binding 
[67, 111].
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Alternative miRISC assembly process
It is commonly held that the Ago:miRNA ratio is approxi-
mately 1:1 and that the model of miRNA-mediated repres-
sion is stoichiometric rather than catalytic. However, 
Gagnon, Novina and colleagues recently proposed an alter-
native miRISC assembly [112]. Based on several lines of 
evidence (e.g., quantitative proteomics and RT-qPCR), 
the authors demonstrated an at least several-fold cellular 
excess of miRNA molecules relative to Ago1-4 proteins, 
and they proved the existence of Ago-free miRNAs [112]. 
Consistent with this result, other researchers have observed 
an excess of total miRNAs in comparison to Ago-bound 
miRNAs [113, 114]. Thus, it might be a general rule that 
Ago is a limiting factor and that miRNA needs to compete 
for loading into miRISC.
The proposed alternative RISC assembly pathway 
implies a catalytic mode of miRNA function, wherein Agos 
first anneal miRNA guide strands to target transcripts, dis-
sociate from the miRNA-mRNA duplexes, bind another 
miRNA/miRNA* or miRNA-mRNA duplex, and finally 
trigger silencing activity (which is, however, less efficient 
for pre-annealed miRNA-mRNA than for the canonical 
pathway). This results in miRNA protection and cellular 
stabilization [115, 116] and allows for the association of 
multiple miRNAs to mRNAs. This pathway may explain 
the specificity of miRNA binding to sponges and compet-
ing endogenous RNAs (ceRNAs) (see Sect. “Modulation of 
miRNA interactome”) [112].
Importantly, the authors demonstrated direct interactions 
between Ago proteins and pre-annealed miRNA-mRNA 
duplexes [112]. Their result is not entirely unexpected, as 
several earlier in vitro studies showed Ago binding to pre-
annealed miRNA-mRNA duplexes [117–119]. The flexible 
structure of Ago2 [67] may allow its loading with such a 
complex by appropriate spatial orientation of Ago domains. 
Together, the studies by Gagnon, Novina and colleagues 
shed new light on miRNA-mediated mechanisms, but the 
scale and importance of this alternative mechanism need to 
be determined.
miRNA‑binding sites and their identification
Characteristics of miRNA-binding sites
In the canonical pathway, miRISC (guided by the single 
miRNA strand) finds partially complementary sequences in 
an mRNA and binds to the transcript (Fig. 2e). However, 
the detailed mechanism by which miRISC finds the miRNA 
target site is still unknown. It is thought to be a result of a 
diffusion-controlled process rather than transcript scanning 
by miRISCs [120, 121]. The efficiency of miRISCs bind-
ing to their targets was shown to depend on RNA structural 
factors, such as target sequence accessibility [122–126].
The occurrence of the minimal perfect watson–Crick 
pairing between the miRNA and the targeted mRNA 
sequence is essential for miRNA-mediated gene expres-
sion regulation, at least in the specific region called the 
“seed” region (2–7 nucleotides at the 5′ end of the miRNA) 
(Fig. 2e) [127, 128]. Apart from the canonical pairing site, 
the rest of the sequence (the 3′ end) may form an additional 
matching region called the 3′-supplementary or 3′-com-
pensatory site [129, 130], but nucleotides 9–12 tend to be 
mismatched to prevent Ago2-mediated cleavage of mRNAs 
[129]. The importance of “seed” pairing is well proven 
for the regulatory functions of miRNAs [67, 129]; thus, 
isomiRs with shifted 5′ ends may regulate different tar-
gets because of the changed “seed” sequence [35, 39, 96]. 
However, recent global analyses showed that only <40 % 
Fig. 2  miRISC assembly in human cells. a The first step is miRISC 
loading, when the miRNA/miRNA* duplex is transferred from Dicer 
to Ago in the miRISC loading complex (RLC). b Next, domain N 
of Ago actively wedges between miRNA strands and c the PAZ 
domain of Ago unwinds the miRNA duplex. d The passenger strand 
is removed from miRISC and undergoes rapid degradation. e miRNA 
within mature miRISC binds with imperfect complementarity to its 
target sites. See text for more details
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miRNA-target interactions involve uninterrupted watson-
Crick base pairing in the “seed” region [131]. Moreover, 
several non-canonical interactions within the “seed” region 
were found to be functional [131–134], which suggests that 
miRISC may be more flexible in target binding than previ-
ously anticipated.
Until recently, functional miRNA-binding sites were 
thought to be usually localized within the 3′UTR [129] but 
might also be present within the coding sequence (CDS) 
[135–139] and the 5′UTR [140–142]. Surprisingly, the 
results from genome-wide analyses of miRNA-binding 
sites, performed by the Darnell, Tuschl, Sharp and Tol-
lervey groups, clearly indicate that a substantial fraction of 
miRNAs interacts with sequences localized within the CDS 
(Fig. 3) [131, 143–145]. This suggests that the CDS may be 
widely targeted by miRNAs and that these miRNA target 
sequences might be underestimated. However, the function-
ality of the miRNA-binding sites in the 5′UTR and CDS is 
considered to be lower than that of the 3′UTR as miRISC 
may not resist the collision with the scanning small riboso-
mal subunit and rapidly translocating ribosomes [146].
Importantly, the efficiency of miRNA-mediated gene 
expression regulation may depend on the number of 
miRNA-binding sites within regulated targets [147, 148] 
and the distance between these sites [147, 149–151]. The 
more target sites that are present on the transcript, the 
higher the observed silencing efficiency. This phenomenon 
is likely a result of cooperative interactions between neigh-
boring bound miRISCs [128, 147, 149, 151].
Taking the rules for miRNA binding to transcripts 
together, the most efficient target regulation involves mul-
tiple “seed”-containing interactions within the 3′UTR of 
an mRNA. Nevertheless, many non-canonical interactions 
were identified, and their functionality remains to be 
established.
Prediction and identification of miRNA-binding sites
The reliable identification of transcripts that are regulated 
by miRNAs is essential for unraveling the specific cellu-
lar functions of miRNAs (reviewed in [152, 153]). Thus, 
several algorithms have been developed for miRNA target 
predictions including miRANDA [154], RNAhybrid [155, 
156], PicTar [157], TargetScan [158] and PITA [159] (com-
pared in [130, 160]). These algorithms take into account 
i.a. the relevance of “seed” pairing, the sequence conser-
vation among species, the free energy of miRNA-mRNA 
binding and target site accessibility. In addition, new algo-
rithms, for example, miRco (predicting binding sites in a 
cooperativity-permitting distance) [151] and MRedictor 
(accounting for protein-binding sites within miRNA target 
sequence) [161], have been described.
The predicted miRNA-mRNA interactions may contain 
many false positives; thus, the functionality of such inter-
actions needs to be verified experimentally. The methods 
for validating miRNA targets include the use of miRNA 
inhibitors or miRNA mimics in dedicated gene-specific 
expression assays, usually luciferase reporter assays, or in 
high-throughput assays (reviewed in [162, 163]). Global 
methods developed in recent years enabled the analysis of a 
pool of Ago-bound miRNAs [80, 164] and Ago-bound tran-
scripts [143–145] in mammalian cells. The basis for these 
analyses is the use of Uv crosslinking and immunoprecipi-
tation (CLIP) followed by deep sequencing and bioinfor-
matic mapping of the reads ([165, 166], reviewed in [167]). 
Nevertheless, in global analyses of the RNA interactome, 
Fig. 3   The miRNA-binding site distribution in the mammalian tran-
scriptome as revealed by different global analyses of RNAs immu-
noprecipitated with Ago proteins. The method, reference and experi-
mental basics are given for each analysis. The main miRNA targets 
are found in mRNAs and were mapped to 5′UTR, CDS and 3′UTR 
regions (approximate shares of these reads are given in the pie charts). 
A group of “other” reads contains different non-coding RNAs: pseu-
dogenes, intronic and intragenic sequences
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it is challenging to extract a single specific miRNA-mRNA 
interaction from the whole data set. More recently, a novel 
method of crosslinking, ligation, and sequencing of hybrids 
(CLASH) was developed [168] and applied for the high-
throughput identification of miRNA-target pairs [131]. 
CLASH allowed the identification of ~18,000 high-confi-
dence miRNA-target interactions (via Ago1) in human cells 
and provided more precise insights into the miRNA inter-
actome than were possible previously (Fig. 3).
Modulation of the miRNA interactome
Target regulation by miRNAs can be additionally controlled 
by modulation of miRNA-binding sites. Specific factors may 
increase or decrease the number of miRNA target sites and 
block or facilitate miRNA binding. For instance, the presence 
of several alternative polyadenylation sites (PAS) may give 
rise to transcripts that differ in the length of their 3′ sequence 
(reviewed in [169, 170]) and thus the number of miRNA-
binding sites. The selection of the functional PAS may 
depend on the developmental stage of the cells or the tissue 
specificity. For example, miR-206 supresses the expression 
of Pax3 in limb muscle stem cells but not in diaphragm mus-
cle stem cells, because in the latter cells 3′UTR of the Pax3 
transcript is shortened that results in loosing miR-206-bind-
ing sites [171]. Furthermore, specific RNA-binding proteins 
(RBPs) (e.g., Dnd1 or Pumilio) may possess binding sites 
overlapping with miRNA binding sites, causing them to 
interfere with one another [172, 173]. Moreover, post-tran-
scriptional modification of the transcript, i.a., deamination 
of A residues, may create novel miRNA-binding sites [174] 
or eliminate miRNA:mRNA recognition [175]. In addition, 
transcripts that share microRNA response elements (MRes) 
may co-regulate each other through the competitive binding 
of miRNAs [176, 177]. To address this issue, a hypothesis 
regarding competing endogenous RNAs (ceRNAs) was pro-
posed. It suggests that both coding and noncoding RNA may 
crosstalk through MRes with miRNAs [178] and suppress 
the regulatory functions of miRNAs by sequestering them 
and affecting the pool of miRNAs available for target bind-
ing [179–181]. Thus far, different types of long non-coding 
RNAs (lincRNAs) [182] have been described as miRNA 
antagonists, including circular RNAs (circRNAs) [183, 184], 
pseudogenes [185] and viral RNAs [186]. Moreover, many 
other types of RNAs (e.g., rRNA and tRNA) were found to 
interact with miRNAs [131, 143], but the relevance of these 
binding sites remains to be determined.
Variations in miRNA‑mediated mechanisms
The miRISC binds to a targeted mRNA sequence and 
typically downregulates its translation mainly via mRNA 
deadenylation (Fig. 4b), which causes transcript decay 
(Fig. 4d, e) [187–189], or via translation inhibition (Fig. 4a) 
[190–192]. However, the detailed composition of miRISC, 
as well as its regulatory function, is still under investiga-
tion. The main proteins currently known to be involved in 
miRNA-mediated mechanisms are listed in Table 1. 
It is postulated that at least two miRISC components, 
interacting with each other, are crucial in miRNA-medi-
ated mechanisms: Argonaute (see the Sect. “miRISC 
assembly”) and conserved Gw182 protein family mem-
bers. Gw182 is the main component of processing bod-
ies (P-bodies or Gw-bodies; see the Sect. “Transcript 
deadenylation and degradation”). Three paralogs of the 
Gw182 protein (TNRC6A–C) are expressed in vertebrate 
cells (reviewed in [193]). Characteristic features of the 
Gw182 protein family include many glycine-tryptophan 
or tryptophan-glycine repeats (Gw/wG repeats) [194], 
the number and localization of which vary among family 
members. The N-terminal Gw-repeats comprise multiple 
independent Ago-binding sites, called Ago hooks ([195–
198], reviewed in [199]), whereas C-terminal Gw repeats 
are the binding platform for the subunits of deadenylase 
complexes: NOT1 [200–202] and PAN3 [200]. Structur-
ally, the vertebrate and insect proteins are composed of 
three main parts: the N-terminal Ago-binding domain, the 
central ubiquitin-associated (UBA)-like domain and the 
C-terminal silencing domain with the non-canonical RNA 
recognition motif (RRM), which is most likely responsi-
ble for the protein-protein interactions [203]. The silencing 
domain is believed to trigger gene silencing by both trans-
lational repression and mRNA decay [204–207]; it con-
tains a PAM2 motif that interacts with the PABC domain 
of the polyA-binding protein (PABP). This motif allows 
Gw182 to function as a link between Ago and other pro-
teins (Table 1).
Translation regulation: inhibition and rare upregulation
The first postulated miRNA-mediated mechanism was 
translation inhibition without transcript downregula-
tion [190–192]. Protein synthesis inhibition is likely cap 
(m7G)-dependent, because the lack of a natural cap [208] 
or the presence of its analogs impairs this process [209]. 
However, some researchers have reported a mechanism of 
cap-independent, IReS-driven translation repression [210, 
211]. Additionally, the translational step that is inhibited by 
miRNAs remains a matter of debate. The results of ribo-
some profiling experiments suggest the formation of both 
light, monosome- [208, 212] and heavy, active polysome-
containing fractions [213, 214] on mRNA during miRNA-
mediated gene silencing. These findings indicate that pro-
tein synthesis regulation may occur at either translation 
initiation (Fig. 4a, 1–2) or elongation (Fig. 4a, 3–5).
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Fig. 4  miRNA-mediated mechanism of gene expression regulation 
in human cells. Mature miRISC binds miRNA target sites localized 
I mostly within the 3′UTR but also (indicated in orange) II in the 
5′UTR or III in the CDS. There are two main pathways of miRNA-
mediated mechanisms of gene expression regulation: a translation 
inhibition either on initiation (1, 2) or at a post-initiation step (3–5) 
and b deadenylation followed by c decapping and d, e mRNA decay. 
However, some less well-known alternatives, indicated by dashed 
orange lines, have been described: f translation upregulation, g import 
into the nucleus and h alternative splicing modulation, i decapping 
followed by translation inhibition and j deadenylation followed by 
translation inhibition. See text for more details
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The blockage of translation initiation may be caused by 
defects in ribosome recruitment to the regulated mRNA. 
One explanation for such a blockage is the impairment of 
cap recognition resulting from the interference of miRISC-
associated proteins with translation initiation factors 
(Fig. 4a, 1) [209, 215] or from the interaction of miRISC 
with the 5′ cap structure [212, 216]. The second possibility 
is the repression of 60S ribosome subunit joining (Fig. 4a, 
2) [217, 218]. In contrast, the formation of polysomal frac-
tions during miRNA-mediated silencing suggests an oppor-
tunity to inhibit protein synthesis at the post-initiation level 
[210, 213, 214]. This most likely involves a block in elon-
gation (Fig. 4a, 3) [213], ribosome drop-off (Fig. 4a, 4) 
[210] or nascent protein proteolysis (Fig. 4a, 5) [191, 214]. 
However, the significance of these latter mechanisms seems 
to be rather limited.
According to the existing knowledge, translation initia-
tion is extensively regulated (i.a., during mRNA circulari-
zation, cap recognition, initiation complex formation, 40S 
scanning); thus, intuitively, it may be easier to affect any of 
these regulatory points. Therefore, we favor miRNA-medi-
ated translation inhibition at the initiation step rather than 
during elongation. Surprisingly, in the output of miRNA 
interactome revealed by CLASH, the most numerous and 
highly reproducible non-mRNA chimeras were formed 
with the 18S and 28S rRNAs, suggesting miRNA interac-
tions with ribosomes [131]. This is consistent with previ-
ous evidence for the association of miR-206 with nuclear 
pre-ribosomes and cytoplasmic ribosomes [219] and for 
the presence of ribosomal proteins in the Ago-associated 
protein fraction [220]. Such an interaction may imply that 
miRISCs directly interfere with ribosomes and trigger 
translation inhibition.
Interestingly, under certain cellular conditions, such as 
cell cycle arrest in G0/G1, cellular stress or nutrient short-
age, miRNAs may also induce translation upregulation 
(Fig. 4f) [221, 222]. For instance, miR-10a interacts with 
the 5′UTR of mRNAs encoding ribosomal proteins and 
causes an increase in translation [141]. Another example 
is miRNA-mediated translation activation, which is asso-
ciated with Ago and AU-rich elements (ARes) [221]. One 
of the ARe-binding proteins, HuR, is able to derepress 
miRNA-mediated translation inhibition (Table 1) [223]. 
Moreover, miRNA binding may also trigger increased ribo-
some loading and therefore upregulate protein synthesis 
[224].
Transcript deadenylation and degradation
More recently, transcript deadenylation was demonstrated to 
be a widespread effect of miRNA activity (Fig. 4b) [188] 
and is suggested to lead to mRNA degradation (Fig. 4d, 
e). In specific cases, mRNA cleavage by miRISC was also 
reported [225, 226]. Bartel and colleagues have shown 
that most (at least 84 %) of the decreased protein produc-
tion caused by miRNAs is an effect of reduced mRNA lev-
els [189]. Thus, most of the research on miRNA-mediated 
mechanisms currently focuses on the issue of mRNA decay. 
Apart from Ago and Gw182, several other proteins (e.g., 
PABP, deadenylase complexes PAN2–PAN3 and CCR4-
NOT) have been demonstrated to be crucial components of 
the deadenylation mechanism (Table 1) (reviewed in [227]). 
It was proposed that deadenylation in human cells occurs in 
two sequential phases. First, PAN2 (the catalytic subunit of 
the PAN2–PAN3 complex) mediates the initial rapid dead-
enylation; then, two subunits of the CCR4-NOT complex, 
CCR4 (CNOT6/6L) and Caf1 (CNOT7/8), are most likely 
responsible for shortening the polyA tail [228, 229].
The mechanism of deadenylation is being carefully stud-
ied, including the structural aspects of the protein-protein 
interactions, to create a detailed model of deadenylation-
dependent repression and better understand this process 
(reviewed in [230, 231]). It has been demonstrated pre-
viously that PAN3 [232] and TNRC6 possess a PAM2 
motif, which enables them to interact directly with PABP 
(Fig. 4b) [200, 233, 234]. In addition, TNRC6 recruits 
PAN3 (Fig. 4b) [200, 201]. The interaction of the PAN2–
PAN3 complex with PABP likely facilitates deadenylation. 
Conversely, no subunit of the large deadenylase complex 
CCR4-NOT contains a PAM2 motif, though this protein 
complex may cooperate with the TOB protein, which con-
tains such a motif (Fig. 4b). In addition, CNOT1 (a scaffold 
and the large subunit of CCR4-NOT) interacts with TNRC6 
(Fig. 4b) (reviewed in [235]).
Deadenylation may be continued by transcript degrada-
tion either via decapping by DCP1–DCP2 complex activ-
ity (Fig. 4c) and the 5′-to-3′ exonuclease XRN1 (Fig. 4d) 
or by 3′-to-5′ cytoplasmic exonucleases (Fig. 4e) (Table 1) 
(reviewed in [236]). It has been shown that decapping fac-
tors are directly recruited by PAN2–PAN3 and CCR4-NOT 
[200–202]. This binding might be facilitated by the high 
concentration of these proteins in P bodies. These cellular 
compartments are cytoplasmic foci where miRNAs and 
miRNA targets, together with proteins involved in dead-
enylation and decapping, are found. Moreover, translation-
ally repressed mRNAs are stored and degraded in the P bod-
ies ([237], reviewed in [238]). Interestingly, Izaurralde and 
colleagues suggested that miRISC also promotes deadenyla-
tion-independent decapping because of the indirect interac-
tion of decapping factors with miRISC (Fig. 4i) [239].
Translation repression may precede mRNA deadenylation 
and degradation
According to the previous suggestions [208, 216, 
233] and recently published reports [234, 240, 241], 
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translation regulation and mRNA decay following dead-
enylation are thought to be directly connected (Fig. 4j). 
Filipowicz and colleagues have reported that translation 
repression may precede deadenylation and mRNA decay 
[240]. Bushell and colleagues confirmed this observa-
tion and showed that translational inhibition (caused by 
the inhibition of initiation factor eIF4A2 binding) is the 
primary event required for mRNA degradation [241]. 
Izaurralde and colleagues conducted functional assays on 
D. melanogaster and human cells, which indicated that 
miRNA-mediated translational repression and degrada-
tion are mechanistically linked through the interactions 
of Gw182 proteins with PABP and deadenylases [234]. 
It could be expected that this link between translation 
inhibition and deadenylation might function to modulate 
transcript turnover.
miRNA activity in the nucleus
Following the trend of epigenetic research, increasing atten-
tion has recently been paid to short non-coding RNAs (i.a., 
siRNA, miRNA) that may regulate transcription (reviewed 
in [242, 243]). Interestingly, Meister and colleagues identi-
fied heterogeneous nuclear ribonucleoprotein particles, i.e., 
hnRNP-U and hnRNP-F, among proteins immunoprecipi-
tated with Agos [220], which indicates the possible interac-
tion of these proteins with Agos in the nucleus. Moreover, 
it has been shown that importin-8 (Imp8) is an essential 
protein factor required for the miRNA-mediated regulation 
of gene expression and for the localization of Ago2 in the 
nucleus (Table 1) [244].
Surprisingly, a recently published work described a 
TNRC6A paralog that possesses both a nuclear localiza-
tion signal (NLS) and nuclear export signal (NeS) [245]. 
These sequences allow TNRC6A to function as a navigator 
for Ago proteins into and out of the nucleus by exportin-1 
(Table 1) [245]. Also, Dicer was found in the nucleus [246], 
and a non-canonical NLS was recently identified within its 
C-terminal region [247]. However, the role of Dicer in the 
nucleus remains unclear.
Taken together, these results strongly suggest the impor-
tance of Ago protein localization and activity in the nucleus 
(Fig. 4g). Thus far, Ago complexes in the nucleus are 
thought to play a major role in the RNA-mediated alter-
native splicing process involving chromatin remodeling 
(Fig. 4h) [248, 249]. In agreement with these observations, 
high-throughput analysis of the miRNA interactome by 
CLASH identified targets mapped to splice junctions [131]. 
Moreover, the deadenylase complex CCR4-NOT, interact-
ing with miRISC, is proposed to play an auxiliary role in 
transcription elongation [250]. Nevertheless, the detailed 
mechanism of miRNA involvement in transcription regula-
tion is poorly understood.
Based on the results described above and the wide-
spread effect of chromatin remodeling on the regulation 
of gene expression, we anticipate that future research will 
reveal more examples of miRNAs participating in nuclear 
processes.
Implications of miRNA‑mediated mechanisms 
for therapy
The complexity of the abundant miRNA-mRNA interac-
tions arises from the fact that one mRNA may harbor bind-
ing sites for numerous different miRNAs [149, 251]; also, 
one miRNAs may be involved in regulating the expression 
of many transcripts. Thus, aberrant miRNA expression, 
either up- or downregulation, impairs cell homeostasis and 
is associated with a wide variety of human disorders (col-
lected in the Human miRNA Disease Database) [252].
The precise modulation as well as reversal of such 
miRNA alterations is not only a challenge for fundamen-
tal research but also a promising strategy for miRNA-based 
therapy. Such therapy might be achieved by introducing 
miRNA blockers (sponges, inhibitors, anti-miRNAs) or 
miRNA mimics (artificial miRNAs) that may target dys-
regulated miRNA pathways. Recently, an efficient miRNA-
based drug against hepatitis C (miRavisen, anti-miR-122) 
was tested in the second phase of clinical trials [253, 254].
The knowledge of miRNA-mediated mechanisms is also 
very useful for designing improved RNAi-based therapeutic 
tools. A popular trend is the use of pri-/pre-miRNA-based 
shRNA expression cassettes for more efficient and longer 
lasting gene silencing (reviewed in [255, 256]). Another 
example is the use of miRNA-like siRNAs for the down-
regulation of genes responsible for Huntington’s disease 
(HD) and spinocerebellar ataxia type 3 (SCA3), as recently 
described by Corey and colleagues as well as our group 
[257–260]. The principle of this approach is to directly tar-
get the mutation site, i.e., the expanded CAG repeat tract 
in the transcript of the mutant gene. The siRNAs that have 
been developed imitate miRNAs, as they form mismatched 
interactions with the target sequence and possess multiple 
neighboring binding sites on the mutant transcript. Impor-
tantly, the normal allele of the implicated transcript, as 
well as transcripts of other genes containing short CAG 
repeat tracts that are thought to provide only a single bind-
ing site for RISC, is much less efficiently silenced by 
miRNA-like siRNAs. Hence, the multiple RISC-binding 
sites allow for very efficient silencing of the mutant tran-
script, which might result from the cooperative action of 
adjacent miRISCs on the expanded CAG tract [260, 261]. It 
is worth highlighting that the multiple binding sites for the 
CAG repeat-targeting siRNAs are localized within the tran-
script CDS. Analyses of the silencing mechanism of these 
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siRNAs revealed that translational inhibition is involved 
rather than Ago2-mediated mRNA cleavage or mRNA deg-
radation, and a crucial role for the Ago2 and TNRC6A-C 
proteins was demonstrated [261].
Conclusions and future perspectives
Although important advances have been made in miRNA 
research over the past several years, we still remain unable 
to profoundly comprehend the miRNA-based cellular pro-
cesses. Numerous detailed questions remain unanswered, 
and among them are the following: which factor is most 
important in determining the effect of miRNA activity? Is it 
the position of miRNA/mRNA mismatches? Is it the locali-
zation and number of miRNA-binding sites? How miRNAs 
within miRISCs find their binding sites on the transcript 
sequence is also poorly understood. Furthermore, it is not 
clear whether we already know all of the critical factors 
involved in mature miRISC formation and miRNA func-
tioning in the cell.
As new mechanisms (e.g., alternative RISC assembly, 
transcriptional regulation, nuclear activity) are discovered, 
the question of whether they are widespread is of great 
importance. The results indicate that there is no single path-
way of miRNA-mediated regulation common to all miR-
NAs in human cells. Moreover, the contradictory findings 
concerning the specific steps of translation that are inhib-
ited via miRNAs remain very controversial. It seems that 
the variety of systems used to perform miRNA research 
might strongly contribute to the observed discrepancies.
Nevertheless, in agreement with recent results, the pre-
vailing opinion concerning miRNA-mediated mechanisms 
is that silencing is mainly caused by transcript decay, which 
follows mRNA deadenylation. Thus, much effort has been 
made to identify the proteins involved in this process as 
well as interactions that take place between these proteins. 
The relevant information is collected in Table 1. This table 
presents multiple direct protein-protein interactions and 
suggests many indirect associations; however, it is likely 
that other proteins are also involved. we still do not know 
much about the stoichiometry of these interactions or how 
miRNA and transcript binding by miRISC influences pro-
tein interactions within this complex.
More generally, we consider that multiple miRNA-
mediated mechanisms may operate in cells depending on, 
i.e., the nature of the miRNA-mRNA interactions and the 
type of cell or its physiological state. In a single cell, there 
are abundant interactions among mRNAs, miRNAs and 
their variants as well as various protein factors competing 
for interactions with miRISC. Therefore, the notion that the 
specific miRNA/mRNA duplex may activate not one but 
two or more different silencing mechanisms concomitantly 
(e.g., deadenylation and translation inhibition) cannot be 
ruled out.
Over the last few years, a growing body of evidence 
has formed that supports the existence of non-canonical 
miRNA-binding sites, in a sense of: miRNA pairings with 
targets, localization within the CDS and interactions with 
noncoding RNAs. This notion needs to be implemented 
into next-generation MRe prediction algorithms and taken 
into account in analyses of relevant deep sequencing data. 
Also worth highlighting is the fact that miRNA binding to 
non-canonical targets can modulate the levels of miRNAs 
and their canonical functions. Together, it is also likely that 
additional new functions of miRNAs await to be disclosed.
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